Mydecine Innovations Group Inc. Share Price
Equities
MYCOF
CA62849F2008
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0221 USD | +72.58% | +76.80% | +48.32% |
02-23 | Mydecine Innovations Closes Partial Debt Settlement | MT |
02-02 | Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director | CI |
Sales 2021 | 0.01 0.6 | Sales 2022 | - | Capitalization | 7.58M 607M |
---|---|---|---|---|---|
Net income 2021 | -28M -2.24B | Net income 2022 | -11M -881M | EV / Sales 2021 | 5,249,560,605 x |
Net Debt 2021 | 3.01M 241M | Net Debt 2022 | 153K 12.27M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.13
x | P/E ratio 2022 |
-0.44
x | Employees | 3 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.04% |
1 day | +72.58% | ||
1 week | +76.80% | ||
Current month | +137.63% | ||
1 month | +22,000.00% | ||
3 months | +76.80% | ||
6 months | -77.72% | ||
Current year | +48.32% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Roscow
FOU | Founder | - | 26/09/13 |
Damon Michaels
FOU | Founder | - | 26/09/13 |
David Bartch
CEO | Chief Executive Officer | - | 21/06/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Bartch
CEO | Chief Executive Officer | - | 21/06/18 |
Damon Michaels
FOU | Founder | - | 26/09/13 |
Robert Roscow
FOU | Founder | - | 26/09/13 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.0221 | +72.58% | 3,957 |
25/04/24 | 0.0128 | +116.95% | 601 |
24/04/24 | 0.0059 | -45.87% | 3,810 |
23/04/24 | 0.0109 | -1.80% | 2,131 |
22/04/24 | 0.0111 | -11.20% | 406 |
Delayed Quote OTC Markets, April 26, 2024 at 08:26 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+48.32% | 1.36M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MYCOF Stock